Breaking News Instant updates and real-time market news.

AVGO

Broadcom

$475.18 /

+9.4 (+2.02%)

07:05
06/07/21
06/07
07:05
06/07/21
07:05

Broadcom price target raised to $550 from $500 at Baird

Baird analyst Tristan Gerra raised the firm's price target on Broadcom to $550 from $500 and keeps an Outperform rating on the shares. The analyst said the company's business is alive and well despite a very high margin profile ad relatively low R&D profile, validating its strategy and execution. He said lead times have surged in the past few quarters and he expects them to remain well above normal through the rest of the year even as they have stabilized recently.

AVGO Broadcom
$475.18 /

+9.4 (+2.02%)

06/07/21 Baird
Broadcom price target raised to $550 from $500 at Baird
06/04/21 Morgan Stanley
Broadcom price target raised to $555 from $538 at Morgan Stanley
06/04/21 Wells Fargo
Broadcom price target raised to $475 from $450 at Wells Fargo
06/04/21 KeyBanc
Broadcom price target raised to $565 from $540 at KeyBanc

TODAY'S FREE FLY STORIES

Hot Stocks
Herborium Group reports Q1 sales up 19.7% » 08:41
06/23/21
06/23
08:41
06/23/21
08:41
HBRM

Herborium Group

/

+

Herborium Group announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HBRM Herborium Group
/

+

Syndicate
BioXcel Therapeutics 3.155M share Spot Secondary priced at $31.70 » 08:41
06/23/21
06/23
08:41
06/23/21
08:41
BTAI

BioXcel Therapeutics

$36.88 /

-1.38 (-3.61%)

The deal priced at bottom…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BTAI BioXcel Therapeutics
$36.88 /

-1.38 (-3.61%)

BTAI BioXcel Therapeutics
$36.88 /

-1.38 (-3.61%)

07:13 Today Truist
BioXcel Therapeutics price target lowered to $125 from $128 at Truist
06/01/21 H.C. Wainwright
BioXcel Therapeutics price target raised to $176 from $170 at H.C. Wainwright
05/11/21 H.C. Wainwright
BioXcel Therapeutics price target lowered to $170 from $175 at H.C. Wainwright
04/09/21 Berenberg
BioXcel Therapeutics initiated with a Buy at Berenberg
BTAI BioXcel Therapeutics
$36.88 /

-1.38 (-3.61%)

  • 23
    Jun
  • 29
    Jul
BTAI BioXcel Therapeutics
$36.88 /

-1.38 (-3.61%)

Hot Stocks
AMMO awarded U.S. Department of Defense contract for developing BM-MPR » 08:39
06/23/21
06/23
08:39
06/23/21
08:39
POWW

AMMO

$8.50 /

+0.75 (+9.68%)

AMMO announce it has been…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
POWW AMMO
$8.50 /

+0.75 (+9.68%)

POWW AMMO
$8.50 /

+0.75 (+9.68%)

04/22/21
Fly Intel: Top five analyst initiations
04/22/21 Lake Street
AMMO initiated with a Buy at Lake Street
04/08/21 Roth Capital
AMMO initiated with a Buy at Roth Capital
POWW AMMO
$8.50 /

+0.75 (+9.68%)

  • 12
    Mar
  • 01
    Dec
POWW AMMO
$8.50 /

+0.75 (+9.68%)

POWW AMMO
$8.50 /

+0.75 (+9.68%)

Hot Stocks
Liminal BioSciences signs share purchase agreement for plasma business sale » 08:39
06/23/21
06/23
08:39
06/23/21
08:39
LMNL

Liminal BioSciences

$4.07 /

+0.03 (+0.74%)

Liminal BioSciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LMNL Liminal BioSciences
$4.07 /

+0.03 (+0.74%)

LMNL Liminal BioSciences
$4.07 /

+0.03 (+0.74%)

06/02/21
Fly Intel: Top five analyst downgrades
06/01/21 Piper Sandler
Liminal BioSciences downgraded to Neutral from Overweight at Piper Sandler
05/18/21 Piper Sandler
Piper says Liminal partnering plasma franchise to Kedrion 'a great catalyst'
03/25/21 Piper Sandler
Liminal BioSciences positioned for transformational year, says Piper Sandler
LMNL Liminal BioSciences
$4.07 /

+0.03 (+0.74%)

Recommendations
Plug Power price target raised to $51 from $50 at B. Riley » 08:39
06/23/21
06/23
08:39
06/23/21
08:39
PLUG

Plug Power

$34.00 /

+4.125 (+13.81%)

B. Riley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLUG Plug Power
$34.00 /

+4.125 (+13.81%)

PLUG Plug Power
$34.00 /

+4.125 (+13.81%)

07:08 Today Canaccord
Canaccord downgrades Plug Power on valuation, higher costs
06:18 Today Barclays
Plug Power price target raised to $27 from $24 at Barclays
05:35 Today Canaccord
Plug Power downgraded to Hold from Buy at Canaccord
06/22/21 Craig-Hallum
Plug Power Q1 filing, reiterated guidance removes overhang, says Craig-Hallum
PLUG Plug Power
$34.00 /

+4.125 (+13.81%)

  • 27
    Jan
  • 17
    Nov
  • 12
    Aug
PLUG Plug Power
$34.00 /

+4.125 (+13.81%)

PLUG Plug Power
$34.00 /

+4.125 (+13.81%)

PLUG Plug Power
$34.00 /

+4.125 (+13.81%)

Hot Stocks
AstroNova says China's CAAC awards company repair station certification » 08:39
06/23/21
06/23
08:39
06/23/21
08:39
ALOT

AstroNova

$13.94 /

+0.18 (+1.31%)

AstroNova announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Upgrade
BofA upgrades UGI Corporation to Buy on earnings growth from renewables » 08:38
06/23/21
06/23
08:38
06/23/21
08:38
UGI

UGI Corporation

$45.50 /

-0.79 (-1.71%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UGI UGI Corporation
$45.50 /

-0.79 (-1.71%)

UGI UGI Corporation
$45.50 /

-0.79 (-1.71%)

08:31 Today BofA
UGI Corporation upgraded to Buy from Neutral at BofA
06/22/21 Barclays
UGI Corporation price target raised to $43 from $39 at Barclays
12/23/20 BofA
UGI Corporation reinstated with a Neutral at BofA
07/16/20 Barclays
UGI Corporation upgraded to Equal Weight from Underweight at Barclays
UGI UGI Corporation
$45.50 /

-0.79 (-1.71%)

Hot Stocks
Amdocs announces release of Amdocs CES21 » 08:38
06/23/21
06/23
08:38
06/23/21
08:38
DOX

Amdocs

$79.02 /

-0.2399 (-0.30%)

Amdocs announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DOX Amdocs
$79.02 /

-0.2399 (-0.30%)

DOX Amdocs
$79.02 /

-0.2399 (-0.30%)

04/01/21 JPMorgan
Amdocs should 'bounce-back' after short report, says JPMorgan
03/31/21 JPMorgan
Prior Amdocs short report turned out a 'great buying opportunity,' says JPMorgan
02/11/21 Oppenheimer
Amdocs assumed with an Outperform at Oppenheimer
02/03/21 Citi
Amdocs price target raised to $87 from $82 at Citi
DOX Amdocs
$79.02 /

-0.2399 (-0.30%)

DOX Amdocs
$79.02 /

-0.2399 (-0.30%)

DOX Amdocs
$79.02 /

-0.2399 (-0.30%)

Hot Stocks
Amdocs launches Experience360 platform » 08:38
06/23/21
06/23
08:38
06/23/21
08:38
DOX

Amdocs

$79.02 /

-0.2399 (-0.30%)

Amdocs announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DOX Amdocs
$79.02 /

-0.2399 (-0.30%)

DOX Amdocs
$79.02 /

-0.2399 (-0.30%)

04/01/21 JPMorgan
Amdocs should 'bounce-back' after short report, says JPMorgan
03/31/21 JPMorgan
Prior Amdocs short report turned out a 'great buying opportunity,' says JPMorgan
02/11/21 Oppenheimer
Amdocs assumed with an Outperform at Oppenheimer
02/03/21 Citi
Amdocs price target raised to $87 from $82 at Citi
DOX Amdocs
$79.02 /

-0.2399 (-0.30%)

DOX Amdocs
$79.02 /

-0.2399 (-0.30%)

DOX Amdocs
$79.02 /

-0.2399 (-0.30%)

Hot Stocks
Chemomab Therapeutics, AGC Biologics expand partnership to manufacture CM-101 » 08:38
06/23/21
06/23
08:38
06/23/21
08:38
CMMB

Chemomab Therapeutics

$22.55 /

+0.16 (+0.71%)

Chemomab Therapeutics and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CMMB Chemomab Therapeutics
$22.55 /

+0.16 (+0.71%)

CMMB Chemomab Therapeutics
$22.55 /

+0.16 (+0.71%)

05/26/21 Cantor Fitzgerald
Chemomab Therapeutics initiated with an Overweight at Cantor Fitzgerald
05/07/21 Oppenheimer
Chemomab Therapeutics initiated with an Outperform at Oppenheimer
CMMB Chemomab Therapeutics
$22.55 /

+0.16 (+0.71%)

Recommendations
DigitalBridge price target raised to $12 from $11 at B. Riley » 08:36
06/23/21
06/23
08:36
06/23/21
08:36
DBRG

DigitalBridge

$8.42 /

-0.07 (-0.82%)

B. Riley analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DBRG DigitalBridge
$8.42 /

-0.07 (-0.82%)

DBRG DigitalBridge
$8.42 /

-0.07 (-0.82%)

07:39 Today Truist
DigitalBridge price target raised to $11 from $8 at Truist
06/21/21 Wells Fargo
Colony Capital initiated with an Overweight at Wells Fargo
DBRG DigitalBridge
$8.42 /

-0.07 (-0.82%)

DBRG DigitalBridge
$8.42 /

-0.07 (-0.82%)

Hot Stocks
Quanta's Medolife Rx announces FDA acceptance of COVID-19 study » 08:36
06/23/21
06/23
08:36
06/23/21
08:36
QNTA

Quanta

/

+

Medolife Rx announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
QNTA Quanta
/

+

Hot Stocks
Entera Bio announce phase 2 BMD data for EB613 » 08:36
06/23/21
06/23
08:36
06/23/21
08:36
ENTX

Entera Bio

$4.50 /

-0.07 (-1.53%)

Entera Bio announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENTX Entera Bio
$4.50 /

-0.07 (-1.53%)

ENTX Entera Bio
$4.50 /

-0.07 (-1.53%)

06/16/21 B. Riley
Entera Bio initiated with a Buy, $9 target at B. Riley
06/16/21 B. Riley
Entera Bio initiated with a Buy at B. Riley
03/22/21 Aegis
Entera Bio initiated with a Buy at Aegis
03/11/21 Maxim
Entera Bio price target raised to $10 from $5 at Maxim
ENTX Entera Bio
$4.50 /

-0.07 (-1.53%)

ENTX Entera Bio
$4.50 /

-0.07 (-1.53%)

Hot Stocks
Genprex begins Acclaim-1 trial for REQORSA in combo for NSCLC treatment » 08:35
06/23/21
06/23
08:35
06/23/21
08:35
GNPX

Genprex

$3.30 /

-0.06 (-1.79%)

Genprex announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GNPX Genprex
$3.30 /

-0.06 (-1.79%)

GNPX Genprex
$3.30 /

-0.06 (-1.79%)

01/26/21 National Securities
Genprex initiated with a Buy at National Securities
Hot Stocks
Luokung Technology subsidiary's HD map standards approved in China » 08:35
06/23/21
06/23
08:35
06/23/21
08:35
LKCO

Luokung Technology

$2.53 /

-0.005 (-0.20%)

Luokung Technology…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LKCO Luokung Technology
$2.53 /

-0.005 (-0.20%)

LKCO Luokung Technology
$2.53 /

-0.005 (-0.20%)

Recommendations
Cassava Sciences price target raised to $111 from $78 at B. Riley » 08:35
06/23/21
06/23
08:35
06/23/21
08:35
SAVA

Cassava Sciences

$77.57 /

-12.08 (-13.47%)

B. Riley analyst Mayank…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SAVA Cassava Sciences
$77.57 /

-12.08 (-13.47%)

SAVA Cassava Sciences
$77.57 /

-12.08 (-13.47%)

04/27/21 B. Riley
B. Riley starts Cassava Sciences at Buy on Alzheimer's focus
04/27/21 B. Riley
Cassava Sciences initiated with a Buy at B. Riley
03/17/21 JonesTrading
JonesTrading starts Alzheimer's 'pure play' Cassava Sciences at Buy
03/17/21 JonesTrading
Cassava Sciences initiated with a Buy at JonesTrading
SAVA Cassava Sciences
$77.57 /

-12.08 (-13.47%)

  • 13
    Nov
SAVA Cassava Sciences
$77.57 /

-12.08 (-13.47%)

SAVA Cassava Sciences
$77.57 /

-12.08 (-13.47%)

Hot Stocks
Iron Mountain sells portfolio of five facilities to ICG for $178M » 08:34
06/23/21
06/23
08:34
06/23/21
08:34
IRM

Iron Mountain

$43.75 /

-1.64 (-3.61%)

Iron Mountain announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IRM Iron Mountain
$43.75 /

-1.64 (-3.61%)

IRM Iron Mountain
$43.75 /

-1.64 (-3.61%)

02/25/21 Wells Fargo
Iron Mountain price target raised to $38 from $32 at Wells Fargo
IRM Iron Mountain
$43.75 /

-1.64 (-3.61%)

IRM Iron Mountain
$43.75 /

-1.64 (-3.61%)

Hot Stocks
XBiotech announces first patient enrolled in clinical trial evaluating XB2001 » 08:33
06/23/21
06/23
08:33
06/23/21
08:33
XBIT

XBiotech

$16.21 /

+0.57 (+3.64%)

XBiotech has enrolled the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XBIT XBiotech
$16.21 /

+0.57 (+3.64%)

Upgrade
First Horizon upgraded to Outperform from Market Perform at Hovde Group » 08:33
06/23/21
06/23
08:33
06/23/21
08:33
FHN

First Horizon

$17.20 /

+0.015 (+0.09%)

Hovde Group analyst Brett…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FHN First Horizon
$17.20 /

+0.015 (+0.09%)

FHN First Horizon
$17.20 /

+0.015 (+0.09%)

10/08/20 Jefferies
First Horizon upgraded to Buy from Hold at Jefferies
09/22/20 Raymond James
First Horizon upgraded to Strong Buy from Outperform at Raymond James
08/20/20 Goldman Sachs
First Horizon reinstated with a Buy at Goldman Sachs
08/17/20 Morgan Stanley
First Horizon resumed with an Equal Weight at Morgan Stanley
FHN First Horizon
$17.20 /

+0.015 (+0.09%)

FHN First Horizon
$17.20 /

+0.015 (+0.09%)

Hot Stocks
Jounce Therapeutics announces anticipated milestones » 08:33
06/23/21
06/23
08:33
06/23/21
08:33
JNCE

Jounce Therapeutics

$7.42 /

-0.33 (-4.26%)

JTX-8064: Establish…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JNCE Jounce Therapeutics
$7.42 /

-0.33 (-4.26%)

JNCE Jounce Therapeutics
$7.42 /

-0.33 (-4.26%)

06/16/21 Roth Capital
JTX-1811 IND-clearance further validates Jounce platform, says Roth Capital
06/15/21 Piper Sandler
Jounce Therapeutics receives $25M milestone from Gilead, says Piper Sandler
04/12/21 Roth Capital
Jounce reported 'very robust' JTX-8064 analysis, says Roth Capital
03/14/21 Piper Sandler
Jounce Therapeutics initiated with an Overweight at Piper Sandler
JNCE Jounce Therapeutics
$7.42 /

-0.33 (-4.26%)

  • 10
    Mar
JNCE Jounce Therapeutics
$7.42 /

-0.33 (-4.26%)

General news
Q1 current account balance deficit widened to $195.7B » 08:33
06/23/21
06/23
08:33
06/23/21
08:33
$ECON

Economic Data

/

+

Consensus deficit…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

Hot Stocks
Jounce Therapeutics provides update on INNATE study at 2021 R&D Day » 08:32
06/23/21
06/23
08:32
06/23/21
08:32
JNCE

Jounce Therapeutics

$7.42 /

-0.33 (-4.26%)

Jounce Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JNCE Jounce Therapeutics
$7.42 /

-0.33 (-4.26%)

JNCE Jounce Therapeutics
$7.42 /

-0.33 (-4.26%)

06/16/21 Roth Capital
JTX-1811 IND-clearance further validates Jounce platform, says Roth Capital
06/15/21 Piper Sandler
Jounce Therapeutics receives $25M milestone from Gilead, says Piper Sandler
04/12/21 Roth Capital
Jounce reported 'very robust' JTX-8064 analysis, says Roth Capital
03/14/21 Piper Sandler
Jounce Therapeutics initiated with an Overweight at Piper Sandler
JNCE Jounce Therapeutics
$7.42 /

-0.33 (-4.26%)

  • 10
    Mar
JNCE Jounce Therapeutics
$7.42 /

-0.33 (-4.26%)

Upgrade
UGI Corporation upgraded to Buy from Neutral at BofA » 08:31
06/23/21
06/23
08:31
06/23/21
08:31
UGI

UGI Corporation

$45.50 /

-0.79 (-1.71%)

BofA analyst Richard…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UGI UGI Corporation
$45.50 /

-0.79 (-1.71%)

UGI UGI Corporation
$45.50 /

-0.79 (-1.71%)

06/22/21 Barclays
UGI Corporation price target raised to $43 from $39 at Barclays
12/23/20 BofA
UGI Corporation reinstated with a Neutral at BofA
07/16/20 Barclays
UGI Corporation upgraded to Equal Weight from Underweight at Barclays
UGI UGI Corporation
$45.50 /

-0.79 (-1.71%)

Hot Stocks
Chemomab Therapeutics, AGC Biologics expand partnership on CM-101 » 08:31
06/23/21
06/23
08:31
06/23/21
08:31
CMMB

Chemomab Therapeutics

$22.55 /

+0.16 (+0.71%)

Chemomab Therapeutics and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CMMB Chemomab Therapeutics
$22.55 /

+0.16 (+0.71%)

CMMB Chemomab Therapeutics
$22.55 /

+0.16 (+0.71%)

05/26/21 Cantor Fitzgerald
Chemomab Therapeutics initiated with an Overweight at Cantor Fitzgerald
05/07/21 Oppenheimer
Chemomab Therapeutics initiated with an Outperform at Oppenheimer
CMMB Chemomab Therapeutics
$22.55 /

+0.16 (+0.71%)

Hot Stocks
Esports Technologies files patent for live streaming wagering technology » 08:31
06/23/21
06/23
08:31
06/23/21
08:31
EBET

Esports Technologies

$20.82 /

+0.41 (+2.01%)

Esports Technologies has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EBET Esports Technologies
$20.82 /

+0.41 (+2.01%)

EBET Esports Technologies
$20.82 /

+0.41 (+2.01%)

  • 15
    Apr
EBET Esports Technologies
$20.82 /

+0.41 (+2.01%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.